Oral contraceptives that contain ethinyl estradiol (0.035 mg) and cyproterone acetate (2 mg) inhibit leukocyte transmigration through endothelial cell monolayers - role of MGF

Author： Hofbauer R.   Frass M.   Gmeiner B.   Salfinger H.   Salzer H.   Kos T.   Wagner O.   Kapiotis S.   Kaye A.D.  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.72, Iss.4, 1999-10, pp. : 652-656

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of combined ethinyloestradiol (0.035 mg) and cyproterone acetate (2 mg) in acne and hirsutism in women with polycystic ovary syndrome

By Falsetti L.   Ramazzotto Francesca   Rosina Barbara  

Journal of Obstetrics & Gynaecology, Vol. 17, Iss. 6, 1997-12 ,pp. : 565-568

Informa Healthcare

Access to resources Recommend Favorite

Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 g of ethinyl estradiol on the human endometrium

By Ludicke F.   Johannisson E.   Helmerhorst F.M.   Campana A.   Foidart J.-M.   Heithecker R.  

Fertility and Sterility, Vol. 76, Iss. 1, 2001-07 ,pp. : 102-107

Elsevier

Access to resources Recommend Favorite

Effect of ethinyl estradiol–cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome

By Karakurt Feridun   Carlioglu Ayse   Kaygusuz Ikbal   Gumus Ilknur   Uz Burak   Akdeniz Derya  

Archives of Gynecology and Obstetrics, Vol. 289, Iss. 1, 2014-01 ,pp. : 135-140

Springer Publishing Company

Access to resources Recommend Favorite

Serum folate and Vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 g ethinyl estradiol

By Sutterlin M.W.   Bussen S.S.   Rieger L.   Dietl J.   Steck T.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 107, Iss. 1, 2003-03 ,pp. : 57-61

Elsevier

Access to resources Recommend Favorite

Climodien® (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints

By Gräser T.   Römer T.   Wiedey K. D.   Janaud A.  

Climacteric, Vol. 4, Iss. 4, 2001-12 ,pp. : 332-342

Informa Healthcare

Access to resources Recommend Favorite